Press release
Theranostics Market Report 2024: Strategies And Recent Developments | Abbott Laboratories, Agilent Technologies Inc., AmeriPath Inc, Beckman Coulter Inc., Thermo Fisher Scientific Inc, Astellas Pharma, Helmholtz Centre for Infection Research, Radiopharm T
Theranostics Market Trends
The Business Research Company offers in-depth market insights through Theranostics Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The theranostics market size has grown rapidly in recent years. It will grow from $98.91 billion in 2023 to $110.41 billion in 2024 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to advancements in molecular imaging, shift to value-based healthcare, integration in oncology..
The theranostics market size is expected to see rapid growth in the next few years. It will grow to $164.38 billion in 2028 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to rise in precision medicine initiatives, expanding applications beyond oncology, population aging and chronic diseases, advancements in biomarker discovery, government support and funding.. Major trends in the forecast period include regulatory support, rise of companion diagnostics, increased focus on cancer theranostics, patient engagement and awareness, technological convergence..
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=10823&type=smp
Market Segmentation:
The theranostics market covered in this report is segmented -
1) By Disease Type: Neurological Disorders, Cardiovascular Diseases, Immunological Disorders, Oncology Diseases, Other Diseases
2) By Technology: Polymerase Chain Reaction, Immunohistochemistry, In-Situ Hybridization, Sequencing, Other Technologies
3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users
Major Driver - Rising Cancer Prevalence Fuels Growth In The Theranostics Market
The rising prevalence of cancer is expected to propel the growth of the theranostics market going forward. Cancer refers to uncontrolled cell growth, which impacts various organs and contributes to significant morbidity and mortality worldwide. Theranostics, the integration of therapeutics and diagnostics, offers promising potential in cancer and chronic disease management. This approach enables personalized and targeted treatments by combining diagnostic and therapeutic capabilities, presenting opportunities for innovation in the healthcare industry. Hence, the increase in number of cancer patients will contribute to the growth of the theranostics market. For instance, in January 2022, according to the National Cancer Institute (NCI), a US-based government agency of the National Institutes of Health (NIH) dedicated to cancer research, prevention, and treatment, In the United States, approximately 5.4% of the population, or 18.1 million individuals, are cancer survivors. In addition, there were 623,405 people living with metastatic breast, prostate, lung, colorectal, or bladder cancer or metastatic melanoma in 2022, a number projected to rise to 693,452 by 2025. Therefore, the rising prevalence of cancer is driving the theranostics market.
Competitive Landscape:
Major companies operating in the theranostics market report are Abbott Laboratories, Agilent Technologies Inc., AmeriPath Inc, Beckman Coulter Inc., Thermo Fisher Scientific Inc, Astellas Pharma, Helmholtz Centre for Infection Research, Radiopharm Theranostics Ltd, Alpha- Theranostics, UNIVERZITET U NOVOM SADU, Cardio-Theranostics LLC, Curium, SoFi Technologies Inc., Theradiag, Cell Theranostics, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc, Qiagen NV, Foundation Medicine Inc, Leica Biosystems Nussloch GmBH, Pfizer Inc., Siemens Healthineers, Advanced Accelerator Applications, AstraZeneca plc, Bayer AG, Bio-Rad Laboratories, The Bristol-Myers Squibb Company, Danaher Corporation, MilliporeSigma, Illumina Inc., Merck KGaA, Roche Diagnostics Corporation, PerkinElmer Inc.
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/theranostics-global-market-report
Top Trend - Theranostics Market Embraces Technological Integration
The integration of imaging and treatment technologies is a key trend gaining popularity in the theranostics market. Major companies operating in the theranostics market are integrating multiple imaging and treatment technologies to provide more accurate and personalized treatments for a wide range of medical conditions, enhance patient care, and sustain their position in the market. For instance, in March 2021, GE HealthCare Technologies Inc., a US-based medical technology company, launched StarGuide, latest SPECT/CT technology, aimed at facilitating research for clinicians. This advanced system incorporates the latest Cadmium Zinc Telluride (CZT) technology, which enables healthcare providers to gain deeper insights into patient conditions and improve patient outcomes across various care areas. With its digital focus detectors and 360-degree imaging, StarGuide is expected to bolster precision health and enhance theranostic capabilities in nuclear medicine.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Theranostics Market Characteristics
3. Theranostics Market Trends And Strategies
4. Theranostics Market - Macro Economic Scenario
5. Theranostics Market Size And Growth
…..
27. Theranostics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Theranostics Market Report 2024: Strategies And Recent Developments | Abbott Laboratories, Agilent Technologies Inc., AmeriPath Inc, Beckman Coulter Inc., Thermo Fisher Scientific Inc, Astellas Pharma, Helmholtz Centre for Infection Research, Radiopharm T here
News-ID: 3431786 • Views: …
More Releases from The Buisness Research Company
Robotic Total Stations Market Growth Outlook Through 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Robotic Total Stations Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $1.39 Bn In 2028…
Advancing Gastroenterology: EPI Therapeutics and Diagnostics Market Trends 2024- …
The exocrine pancreatic insufficiency (epi) therapeutics and diagnostics market size has grown strongly in recent years. It will grow from $5.24 billion in 2023 to $5.69 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increased prevalence of underlying conditions, advancements in diagnostic tools, pharmaceutical developments, rising global healthcare access.
The exocrine pancreatic insufficiency (epi) therapeutics…
Image Recognition Industry - Key Market Dynamics and Trends 2024-2033
The image recognition market size has grown rapidly in recent years. It will grow from $46.53 billion in 2023 to $54.54 billion in 2024 at a compound annual growth rate (CAGR) of 17.2%. The growth in the historic period can be attributed to rise in advances in deep learning and neural networks, growth in computer vision technologies, increase in image data availability, adoption of image recognition in healthcare,…
Overnight Face Mask Market Report 2024: Market Insights
The overnight face mask market size has grown strongly in recent years. It will grow from $23.62 billion in 2023 to $25.56 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to skin care trends, marketing and influencers, increasing disposable income, consumer education.
The overnight face mask market size is expected to see strong growth in the…
More Releases for Theranostics
Theranostics Market Is Booming Worldwide Just Published
Global Theranostics Market: An Overview
Theranostics is a new field of medicine which relies on targeted therapies to conduct specific targeted tests. These tests are mainly used for various forms of cancers. The key concern in the therapeutics involve patient centric care with the help of more personalised and precise approach. The technique relies on the use of diagnostic and therapeutic applications to form a single agent. The system is known…
Theranostics Market Positioning and Growing Market Share Worldwide
Coherent Market Insights Market Reports offers 2019 Depth Insights report on Global Theranostics market that evaluates industry growth trends, through historical data and estimates future prospects based on comprehensive research. The report also identifies the factors driving this market, various restraints and opportunities impacting it along with the adoption trends for the period 2018-2026.
The Theranostics market research report displays the latest industry insights with future trends and analysis of the…
Theranostics Market Scope and Opportunities Analysis 2016 - 2014
Global Theranostics Market: Overview
Theranostics is considered as a fusion of diagnostics and drug therapy. It helps in optimizing safety, effective results, and streamlining of overall drug development. The combination of advanced diagnostic tests and effective medical drugs has been given several names, such as pharmacodiagnostics, integrated medicine, Dx/Rx partnering, and companion diagnostics. Research activities in this field are contributing extensively towards the growth of the market, as this is considered…
Growth Prospects of Global Theranostics Market During 2016 – 2024
Theranostics is considered as a fusion of diagnostics and drug therapy. It helps in optimizing safety, effective results, and streamlining of overall drug development. The combination of advanced diagnostic tests and effective medical drugs has been given several names, such as pharmacodiagnostics, integrated medicine, Dx/Rx partnering, and companion diagnostics. Research activities in this field are contributing extensively towards the growth of the market, as this is considered as a highly…
Recent Research: Nanomaterials in Theranostics Market Analysis to 2024
Global Nanomaterials in Theranostics Market: Overview
The application of theranostics in nanomedicine is a fast emerging paradigm, which involves the use of nanoparticles or nanoscale materials for a variety of diagnostic, imaging, and therapeutic applications. Recent research efforts have been increasingly focused on designing functional nanomaterials for non-invasive imaging of diseases, including bioimaging and biosensing, advanced biomarkers, and targeted delivery of therapeutic drugs. Efforts are also underway for developing highly…
Theranostics Market: Opportunities and Forecasts, 2016 - 2024
Global Theranostics Market: Overview
Theranostics is considered as a fusion of diagnostics and drug therapy. It helps in optimizing safety, effective results, and streamlining of overall drug development. The combination of advanced diagnostic tests and effective medical drugs has been given several names, such as pharmacodiagnostics, integrated medicine, Dx/Rx partnering, and companion diagnostics. Research activities in this field are contributing extensively towards the growth of the market, as this is considered…
